BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/25/2024 8:28:58 AM | Browse: 291 | Download: 1494
 |
Received |
|
2023-12-01 14:31 |
|
Peer-Review Started |
|
2023-12-01 14:31 |
|
First Decision by Editorial Office Director |
|
2023-12-07 02:51 |
|
Return for Revision |
|
2023-12-07 02:51 |
|
Revised |
|
2023-12-15 15:16 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-01-03 03:00 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-01-03 07:10 |
|
Articles in Press |
|
2024-01-03 07:10 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-01-18 07:42 |
|
Publish the Manuscript Online |
|
2024-01-25 08:28 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Translational Research |
| Article Title |
Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zi-Zheng Wu, Yuan-Jun Wei, Tong Li, Jie Zheng, Yin-Feng Liu and Meng Han |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Meng Han, MD, Director, Director, Breast Disease Diagnosis and Treatment Center, The First Hospital of Qinhuangdao, No. 258 Wenhua Road, Haigang District, Qinhuangdao 066000, Hebei Province, China. menghan68527@163.com |
| Key Words |
Breast cancer; Prognosis; Gene signature; The Cancer Genome Atlas; The Gene Expression Omnibus |
| Core Tip |
Breast cancer (BC), a leading malignant disease, affects women all over the world. Cancer associated fibroblasts (CAFs) stimulate epithelial-mesenchymal transition, and induce chemoresistance and immunosuppression. We introduced a newly-discovered CAFs-associated gene signature using IL18, MYD88, GLIPR1, TNN, BHLHE41, DNAJB5, FKBP14, and XG, which can be employed to estimate BC patient outcomes conveniently and accurately. |
| Publish Date |
2024-01-25 08:28 |
| Citation |
ZZ Wu, YJ Wei, Li T, Zheng J, Liu YF, Han M. Identification and validation of a new prognostic signature based on cancer-associated fibroblast-driven genes in breast cancer. World J Clin Cases 2024; 12(4): 700-720
|
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i4/700.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i4.700 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
